Kevin Prehn - 08 Dec 2023 Form 4 Insider Report for UNIVERSAL TECHNICAL INSTITUTE INC (UTI)

Role: Concorde Division President
Signature: /s/ Christopher Kevane, attorney-in-fact for Kevin Prehn
Issuer symbol: UTI
Transactions as of: 08 Dec 2023
Net transactions value: -$3,742
Form type: 4
Filing time: 13 Dec 2023, 08:57:47 UTC
Previous filing: 12 Dec 2023
Next filing: 16 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	UTI	Common Stock, $0.0001 par value	Options Exercise	$0	+1,160		$0.000000	1,160	08 Dec 2023	Direct	F1
transaction	UTI	Common Stock, $0.0001 par value	Tax liability	$3,742	-315	-27%	$11.88	845	08 Dec 2023	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	UTI	Restricted Stock Units	Options Exercise	$0	-1,160	-33%	$0.000000	2,320	08 Dec 2023	Common Stock, $0.0001 par value	1,160		Direct	F1, F3
transaction	UTI	Restricted Stock Units	Award	$0	+28,464		$0.000000	28,464	08 Dec 2023	Common Stock, $0.0001 par value	28,464		Direct	F1, F4
transaction	UTI	Performance Units	Award	$0	+53,370		$0.000000	53,370	08 Dec 2023	Common Stock, $0.0001 par value	53,370		Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of UTI Common Stock.
F2	Shares withheld to satisfy tax liability for the vesting of restricted stock units granted on 12/8/2022.
F3	The restricted stock units vest in three equal annual installments beginning on December 8, 2023.
F4	Vesting of restricted stock units granted on 12/08/2022.
F5	Each performance unit represents a contingent right to receive one share of the UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2026 and 40% of which vest based on adjusted EBITDA for the fiscal year ending September 30, 2026.